IL1B and metabolic dysfunction-associated steatotic liver disease: In mice with high-fat diet-induced nonalcoholic fatty liver disease (NAFLD), upregulation of IL-1β in hepatocytes contributes to increased fat aggregation, liver inflammation, insulin resistance and liver fibrosis (20).